Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
Böhlen TT, Germond JF, Desorgher L, Veres I, Bratel A, Landström E, Engwall E, Herrera FG, Ozsahin EM, Bourhis J, Bochud F, Moeckli R. Böhlen TT, et al. Among authors: bourhis j. Radiother Oncol. 2024 May;194:110177. doi: 10.1016/j.radonc.2024.110177. Epub 2024 Feb 18. Radiother Oncol. 2024. PMID: 38378075 Free article.
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Kinj R, Gaide O, Jeanneret-Sozzi W, Dafni U, Viguet-Carrin S, Sagittario E, Kypriotou M, Chenal J, Duclos F, Hebeisen M, Falco T, Geyer R, Gonçalves Jorge P, Moeckli R, Bourhis J. Kinj R, et al. Among authors: bourhis j. Clin Transl Radiat Oncol. 2024 Feb 8;45:100743. doi: 10.1016/j.ctro.2024.100743. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38362466 Free PMC article.
Hybrid ultra-high and conventional dose rate treatments with electrons and photons for the clinical transfer of FLASH-RT to deep-seated targets: A treatment planning study.
Böhlen TT, Zeverino M, Germond JF, Kinj R, Schiappacasse L, Bochud F, Herrera F, Bourhis J, Moeckli R. Böhlen TT, et al. Among authors: bourhis j. Radiother Oncol. 2024 Dec;201:110576. doi: 10.1016/j.radonc.2024.110576. Epub 2024 Oct 11. Radiother Oncol. 2024. PMID: 39395673 Free article.
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study.
Cloître M, Benkhaled S, Boughdad S, Schaefer N, Prior JO, Zeverino M, Berthold D, Tawadros T, Meuwly JY, Martel P, Rohner C, Heym L, Duclos F, Vallet V, Valerio M, Bourhis J, Herrera F. Cloître M, et al. Among authors: bourhis j. Cancers (Basel). 2024 May 31;16(11):2097. doi: 10.3390/cancers16112097. Cancers (Basel). 2024. PMID: 38893216 Free PMC article.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group. Blanchard P, et al. Among authors: bourhis j. Lancet Oncol. 2015 Jun;16(6):645-55. doi: 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6. Lancet Oncol. 2015. PMID: 25957714
733 results